Douglas Galasko

机构：University of California San Diego · ORCID：0000-0001-6195-3241

发表论文 560 篇 · 总被引 87638 次 · h-index 123

代表论文

• Phospho-tau serine-262 and serine-356 as biomarkers of pre-tangle soluble tau assemblies in Alzheimer’s disease (2025 · Nature Medicine · 被引 63)
• Safety and efficacy of long-term gantenerumab treatment in dominantly inherited Alzheimer's disease: an open-label extension of the phase 2/3 multicentre, randomised, double-blind, placebo-controlled platform DIAN-TU trial (2025 · The Lancet Neurology · 被引 52)
• α-Synuclein Seed Amplification Assay Amplification Parameters and the Risk of Progression in Prodromal Parkinson Disease (2025 · Neurology · 被引 36)
• Multi-ancestry genome-wide meta-analysis of 56,241 individuals identifies known and novel cross-population and ancestry-specific associations as novel risk loci for Alzheimer’s disease (2025 · Genome biology · 被引 22)
• Comprehensive cross-sectional and longitudinal comparisons of plasma glial fibrillary acidic protein and neurofilament light across FTD spectrum disorders (2025 · Molecular Neurodegeneration · 被引 20)
• Treatment‐related amyloid clearance (TRAC): a framework to characterize patients in the era of anti‐amyloid therapies (2025 · Alzheimer s & Dementia · 被引 19)